We found a significant association of EGFR expression with tumor stage and disease-free survival, which are the most important prognostic factors in head and neck squamous cell carcinoma; therefore, EGFR expression can be used as a prognostic biomarker in head and neck squamous cell carcinoma. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.